January 3, 2019 - Page 16 of 23

NASDAQ Companies - January 3, 2019

Jounce Therapeutics Completed Enrollment in First Cohort of Phase 1 Clinical Trial with its PD-1 Inhibitor, JTX-4014

Dose Escalation Trial in Patients with Solid Tumors CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: […]

NASDAQ Companies - January 3, 2019

BioXcel Therapeutics Reports Positive Human Proof-of-Concept Data for Acute Treatment of Agitation in Patients with Alzheimer’s Disease

Primary endpoint (safety and tolerability) met, with clinical benefit observed in 7 of 10 patients Proof-of-Concept established in agitated patients […]

NASDAQ Companies - January 3, 2019

Wave Life Sciences Duchenne Muscular Dystrophy Clinical Trial Selected for FDA Complex Innovative Trial Designs Pilot Program

Suvodirsen (WVE-210201) Phase 2/3 trial chosen in inaugural round of pilot program FDA pilot program is a 21st Century Cures […]

NASDAQ Companies - January 3, 2019

PRGX Announces Appointment of New Chief Financial Officer

ATLANTA, Jan. 03, 2019 (GLOBE NEWSWIRE) — PRGX Global, Inc. (Nasdaq: PRGX), a global leader in Recovery Audit and Spend […]

NASDAQ Companies - January 3, 2019

Intra-Cellular Therapies to Present at the 37th Annual J.P. Morgan Healthcare Conference

NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics […]

NASDAQ Companies - January 3, 2019

Stein Mart to Present at the 2019 ICR Conference

JACKSONVILLE, Fla., Jan. 03, 2019 (GLOBE NEWSWIRE) — Stein Mart, Inc. (NASDAQ: SMRT) announced today that its chief executive officer, […]

NASDAQ Companies - January 3, 2019

Kratos Awarded $17 Million Task Order for Continued Royal Saudi Naval Forces Training Support

SAN DIEGO, Jan. 03, 2019 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a leading National Security […]

NASDAQ Companies - January 3, 2019

Scholar Rock to Present at the 37th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) — Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on […]

NASDAQ Companies - January 3, 2019

Fulgent Genetics and Columbia University Irving Medical Center Partner on Expanded Carrier Screening

TEMPLE CITY, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) — Fulgent Genetics (NASDAQ: FLGT) and the Precision Genomics Laboratory (PGL), in […]

NASDAQ Companies - January 3, 2019

Replimune Highlights Company Progress and Expected 2019 Milestones Ahead of Presentation at the 37th Annual JPMorgan Healthcare Conference

RP1: U.S. Enrollment Opened for Phase 1/2 Clinical Trial in Combination with Nivolumab in Patients with Solid Tumors RP1: Randomized […]